Autocrine IGF signaling supports progression of the CML blast crisis phase, and, conversely, inhibition of IGF-1R reduces viability and proliferation of BCR-ABL+ cells [20]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.